Biogen
BIIB
BIIB
1,024 hedge funds and large institutions have $34.1B invested in Biogen in 2022 Q4 according to their latest regulatory filings, with 159 funds opening new positions, 323 increasing their positions, 358 reducing their positions, and 96 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,024
Holders Change
+45
Holders Change %
+4.6%
% of All Funds
16.52%
Holding in Top 10
24
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+14.29%
% of All Funds
0.39%
New
159
Increased
323
Reduced
358
Closed
96
Calls
$1.29B
Puts
$1.51B
Net Calls
-$216M
Net Calls Change
-$369M
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
+$303M |
| 2 |
BlackRock
New York
|
+$115M |
| 3 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$83.1M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$79.5M |
| 5 |
Barclays
London,
United Kingdom
|
+$79.4M |
Top Sellers
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$160M |
| 2 |
Millennium Management
New York
|
-$159M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$125M |
| 4 |
Goldman Sachs
New York
|
-$116M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$112M |
